Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambion, Inc. (often referred to as Ambion Life Technologies) was a leading biotechnology company specializing in the development and supply of RNA-based life science research and molecular biology products. Founded in 1989 by Dr. Matt Winkler, the company became widely known as "The RNA Company," providing a comprehensive portfolio of kits, enzymes, and reagents for RNA isolation, stability, detection, and analysis, including siRNA and microRNA reagents. In 2006, Applied Biosystems acquired Ambion's Research Products Division for $273 million, while its diagnostics division spun out to form Asuragen. Following subsequent mergers and acquisitions, Ambion's product lines became part of Life Technologies and are currently marketed under Thermo Fisher Scientific.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambion Life Technologies.